Alpha 2.0
Login Register
» Authors » L S E van Egdom

L S E van Egdom

Explore the profile of L S E van Egdom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 96
Followers 0
Related Specialties
Oncology
General Surgery
Radiology
Top 10 Co-Authors
L B Koppert
M Lagendijk
J A Hazelzet
M A M Mureau
H F Lingsma
N van Leeuwen
C Verhoef
M A de Kock
S Siesling
A Jager
Published In
Eur J Surg Oncol
Breast Cancer
Eur J Radiol
Ann Surg Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I-III breast cancer patients
van Egdom L, de Ligt K, de Munck L, Koppert L, Mureau M, Rakhorst H, et al.
Breast Cancer . 2021 Nov; 29(2):324-335. PMID: 34780034
Purpose: Delayed breast reconstruction (DBR) is a valid option for postmastectomy breast cancer patients who have a desire for breast reconstruction but are not considered suitable for immediate breast reconstruction...
2.
Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers
van Egdom L, de Kock M, Apon I, Mureau M, Verhoef C, Hazelzet J, et al.
Breast Cancer . 2019 Dec; 27(3):426-434. PMID: 31832891
Purpose: The aim of this study was to compare patient-reported outcomes (PROs) of BRCA1/2 mutation carriers, either after bilateral prophylactic mastectomy (BPM) or during breast surveillance, to improve shared decision-making...
3.
'Reply to: Moving forward with value-based healthcare: The need for a scientific approach.'
van Egdom L, Hazelzet J, Koppert L
Eur J Surg Oncol . 2019 May; 45(7):1300. PMID: 31072621
No abstract available.
4.
Implementation of Value Based Breast Cancer Care
van Egdom L, Lagendijk M, van der Kemp M, van Dam J, Mureau M, Hazelzet J, et al.
Eur J Surg Oncol . 2019 Jan; 45(7):1163-1170. PMID: 30638807
Purpose: Adding value of care to patients is crucial for all stakeholders. The use of both provider and patient reported outcome data was implemented in a single academic breast cancer...
5.
Patient-Reported Outcome Measures May Add Value in Breast Cancer Surgery
Lagendijk M, van Egdom L, van Veen F, Vos E, Mureau M, van Leeuwen N, et al.
Ann Surg Oncol . 2018 Sep; 25(12):3563-3571. PMID: 30178391
Purpose: Considering the comparable prognosis in early-stage breast cancer after breast-conserving therapy (BCT) and mastectomy, quality of life should be a focus in treatment decision(s). We retrospectively collected PROs and...
6.
Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial
van Egdom L, Lagendijk M, Heijkoop E, Koning A, van Deurzen C, Jager A, et al.
Eur J Radiol . 2018 Jun; 104:94-100. PMID: 29857873
Background: Accurate measurement of tumour response during and after neoadjuvant chemotherapy (NAC) is important and may influence treatment decisions in invasive breast cancer patients. Breast MRI forms the gold standard...
7.
Patient reported outcome measures in breast cancer patients
Lagendijk M, van Egdom L, Richel C, van Leeuwen N, Verhoef C, Lingsma H, et al.
Eur J Surg Oncol . 2018 Apr; 44(7):963-968. PMID: 29678302
Introduction: In the International Consortium for Health Outcome Measures (ICHOM) breast cancer outcome set Patient Reported Outcome Measurements (PROMs) form an important but rather innovative part. Few data exist on...